Tenders of Aok Plus The Health Fund For Saxony And

Tenders of Aok Plus The Health Fund For Saxony And

AOK PLUS The Health Fund For Saxony And Tender

Germany
Closing Date31 May 2025
Tender AmountRefer Documents 
For the tender 'conclusion of non-exclusive AM discount agreements according to Section 130a Paragraph 8 SGB V IWE so-called open-house models for WS Ibuprofen (ATC code according to WHO: M01ae01), restricted to the administration of film-coated tablets'

AOK PLUS The Health Fund For Saxony And Tender

Others
Germany
Closing Date31 Mar 2025
Tender AmountRefer Documents 
To tender for the conclusion of non-exclusive medicament discounts according to § 130a para. 8 Sgb W In the way of a so-called open-house model To the active ingredient Dornase Alfa (atc-code After Who: R05cb13)'

AOK PLUS The Health Fund For Saxony And Tender

Healthcare and Medicine
Germany
Closing Date31 Aug 2025
Tender AmountRefer Documents 
For the tender 'conclusion of non-exclusive drug discount agreement according to Section 130a Paragraph 8 SGB V by means of an open-house model for the active ingredient lisdexamfetamine (ATC code according to WHO: N06BA12)'

AOK PLUS The Health Fund For Saxony And Tender

Others
Germany
Closing Date31 Mar 2025
Tender AmountRefer Documents 
In the context of a so-called open-house model To diversity X-ray contrast media (atc-code According to Who: V08)'

AOK PLUS The Health Fund For Saxony And Tender

Germany
Closing Date28 Feb 2025
Tender AmountRefer Documents 
To the call for tender ' conclusion of non-excl. Am-rabatt arrangements According to § 130a para. 8 Sgb W In the way of a so-called open-house model To the active substance perindopril/indapamide (atc-code According to Who: C09ba04; Amtl. Atc-code: C09ba54')

AOK PLUS The Health Fund For Saxony And Tender

Healthcare and Medicine
Germany
Closing Date31 Aug 2026
Tender AmountRefer Documents 
For the tender 'conclusion of non-exclusive drug discount agreement pursuant to Section 130a Paragraph 8 SGB V by means of an open-house model for the active ingredient tolvaptan (ATC code: C03xa01)'

AOK PLUS The Health Fund For Saxony And Tender

Germany
Closing Date31 Mar 2025
Tender AmountRefer Documents 
To tender for the conclusion of non-exclusive medicament discounts according to § 130a para. 8 Sgb W In the way of a so-called open-house model To the active ingredient Etanercept (atc-code After Who: L04ab01')

AOK PLUS The Health Fund For Saxony And Tender

Germany
Closing Date28 Feb 2025
Tender AmountRefer Documents 
To tender for the conclusion of non-exclusive medicament discounts according to § 130a para. 8 Sgb W In the way of a so-called open-house model To the active ingredient Piribedil (atc-code After Who: N04bc08)'

AOK PLUS The Health Fund For Saxony And Tender

Corrigendum : Closing Date Modified
Germany
Closing Date30 Sep 2025
Tender AmountRefer Documents 
To tender for the conclusion of non-exclusive medicament discounts according to § 130a para. 8 Sgb W In the way of a so-called open-house model To the active ingredient amifampridin (atc-code After Who: N07xx05)'

AOK PLUS The Health Fund For Saxony And Tender

Others
Germany
Closing Date30 Apr 2025
Tender AmountRefer Documents 
To tender for the conclusion of non-exclusive medicament discounts according to § 130a para. 8 Sgb V In The Way A Sog. Open-house Model To the active ingredient Raltegravir (atc-code Who: J05aj01)'
21-30 of 34 active Tenders